58% Of Patients Discontinue Use Of Obesity Meds Before Reaching Meaningful Weight Loss, Study Shows
Forbes Healthcare
JUNE 20, 2024
58% of patients discontinue use of GLP-1 obesity meds before reaching a meaningful level of weight loss. This presents a challenge to payers deciding on coverage.
Let's personalize your content